Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
- Phase 2: Focuses on the drug's effectiveness and further evaluates its safety in a larger group of individuals with the targeted condition
When you work closely with a healthcare professional, you can receive personalized guidance on how to use semaglutide GLP-1 effectively to target belly fat and achieve specific weight loss goals
Following your healthcare provider's guidance is essential to ensure the dosage is effective and safe
The FDA has approved a growing number of medications for weight management, including Xenical (orlistat), Alli (orlistat), Qsymia (phentermine-topiramate), Contrave (bupropion-naltrexone), Saxenda (liraglutide), Imcivree (setmelanotide), Wegovy (semaglutide), Zepbound (tirzepatide), and Foundayo (orforglipron)
More precisely, in early clinical trials, Retatrutide has shown the potential for significant weight loss, with participants on the highest dose losing an average of 28.7% of their body weight over 68 weeks, which is double the weight loss seen with other GLP-1 medications like Ozempic and Wegovy
Clinical studies have demonstrated notable weight loss when the medication is used consistently as directed
US$ 21.71
US$ 25.20
US$ 24.58
US$ 24.11
US$ 23.56
